Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer

Background Cancer increases the risk of thromboembolic events in patients including those receiving anticoagulation treatments. Objectives To compare the efficacy and safety of low molecular weight heparin (LMWH) and oral anticoagulants for the long‐term treatment of venous thromboembolism (VTE) in patients with cancer. Search methods We conducted a comprehensive search for studies of anticoagulation in cancer patients including 1. a February...